BRIEF-Agenus commences phase 1 clinical trial of antibody to treat solid tumors

* Agenus Commences Phase 1 Clinical Trial Of Its CTLA 4 checkpoint antibody to treat solid tumors
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.